Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Livestream 2021
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • CCC Excellence Lecture
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    ERJ open research. 2021 Dec 6. doi: 10.1183/23120541.00457-2021. pii: 00457-2021. pmc: PMC8646001
    Spirometric phenotypes from early childhood to young adulthood: a Chronic Airway Disease Early Stratification study.
    Wang G1,  Hallberg J2,  Charalampopoulos D3,  Sanahuja MC4,  Breyer-Kohansal R5,  Langhammer A6,  Granell R7,  Vonk JM8,  Mian A9,  Olvera N10,  Laustsen LM11,  Rönmark E12,  Abellan A13,  Agusti A14,  Arshad SH15,  Bergström A16,  Boezen HM17,  Breyer MK18,  Burghuber O19,  Bolund AC20,  Custovic A21,  Devereux G22,  Donaldson GC23,  Duijts L24,  Esplugues A25,  Faner R26,  Ballester F27,  Garcia-Aymerich J28,  Gehring U29,  Haider S30,  Hartl S31,  Backman H32,  Holloway JW33,  Koppelman GH34,  Lertxundi A35,  Holmen TL36,  Lowe L37,  Mensink-Bout SM38,  Murray CS39,  Roberts G40,  Hedman L41,  Schlünssen V42,  Sigsgaard T43,  Simpson A44,  Sunyer J45,  Torrent M46,  Turner S47,  Van den Berge M48,  Vermeulen RCH49,  Vikjord SAA50,  Wedzicha JA51,  Maitland van der Zee AH52,  Melén E53
    Author information
    1Dept of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Sichuan, China.
    2Dept of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
    3MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    4ISGlobal, Barcelona, Spain.
    5Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
    6Dept of Public Health and Nursing, Faculty of Medicine and Health Sciences, HUNT Research Centre, Norwegian University of Science and Technology (NTNU), Levanger, Norway.
    7MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
    8Dept of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
    9The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    10Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
    11Dept of Public Health, Environment Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.
    12Dept of Public Health and Clinical Medicine, Section for Sustainable Health, The OLIN Unit, Umeå University, Umeå, Sweden.
    13ISGlobal, Barcelona, Spain.
    14Institut d'investigacions biomediques August Pi I Sunyer, Barcelona, Spain.
    15David Hide Asthma and Allergy Research Centre, Newport, UK.
    16Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
    17Dept of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.
    18Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
    19Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
    20Dept of Public Health, Environment Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.
    21National Heart and Lung Institute, Imperial College London, London, UK.
    22Liverpool School of Tropical Medicine, Liverpool, UK.
    23National Heart and Lung Institute, Imperial College London, London, UK.
    24The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    25Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
    26Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
    27Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
    28ISGlobal, Barcelona, Spain.
    29Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
    30National Heart and Lung Institute, Imperial College London, London, UK.
    31Ludwig Boltzmann Institute for Lung Health, Vienna, Austria.
    32Dept of Public Health and Clinical Medicine, Section for Sustainable Health, The OLIN Unit, Umeå University, Umeå, Sweden.
    33NIHR Southampton Biomedical Research Centre, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
    34University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, The Netherlands.
    35Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.
    36Dept of Public Health and General Practice, HUNT Research Center, NTNU, Levanger, Norway.
    37Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester Academic Health Science Centre, NIHR, Manchester, UK.
    38The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
    39Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester Academic Health Science Centre, NIHR, Manchester, UK.
    40David Hide Asthma and Allergy Research Centre, Newport, UK.
    41Dept of Public Health and Clinical Medicine, Section for Sustainable Health, The OLIN Unit, Umeå University, Umeå, Sweden.
    42Dept of Public Health, Environment Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.
    43Dept of Public Health, Environment Occupation and Health, Danish Ramazzini Centre, Aarhus University, Aarhus, Denmark.
    44Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester Academic Health Science Centre, NIHR, Manchester, UK.
    45ISGlobal, Barcelona, Spain.
    46ib-salut, Area de Salut de Menorca, Menorca, Spain.
    47Royal Aberdeen Children's Hospital NHS Grampian, Aberdeen, UK.
    48University Medical Center Groningen, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, The Netherlands.
    49Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
    50Dept of Public Health and Nursing, Faculty of Medicine and Health Sciences, HUNT Research Centre, Norwegian University of Science and Technology (NTNU), Levanger, Norway.
    51National Heart and Lung Institute, Imperial College London, London, UK.
    52Dept of Respiratory Medicine, Amsterdam University Medical Centers (UMC), University of Amsterdam.
    53Dept of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
    Abstract

    BACKGROUND: The prevalences of obstructive and restrictive spirometric phenotypes, and their relation to early-life risk factors from childhood to young adulthood remain poorly understood. The aim was to explore these phenotypes and associations with well-known respiratory risk factors across ages and populations in European cohorts.

    METHODS: We studied 49 334 participants from 14 population-based cohorts in different age groups (≤10, >10-15, >15-20, >20-25 years, and overall, 5-25 years). The obstructive phenotype was defined as forced expiratory volume in 1 s (FEV)/forced vital capacity (FVC) z-score less than the lower limit of normal (LLN), whereas the restrictive phenotype was defined as FEV/FVC z-score ≥LLN, and FVC z-score

    RESULTS: The prevalence of obstructive and restrictive phenotypes varied from 3.2-10.9% and 1.8-7.7%, respectively, without clear age trends. A diagnosis of asthma (adjusted odds ratio (aOR=2.55, 95% CI 2.14-3.04), preterm birth (aOR=1.84, 1.27-2.66), maternal smoking during pregnancy (aOR=1.16, 95% CI 1.01-1.35) and family history of asthma (aOR=1.44, 95% CI 1.25-1.66) were associated with a higher prevalence of obstructive, but not restrictive, phenotype across ages (5-25 years). A higher current body mass index (BMI was more often observed in those with the obstructive phenotype but less in those with the restrictive phenotype (aOR=1.05, 95% CI 1.03-1.06 and aOR=0.81, 95% CI 0.78-0.85, per kg·m increase in BMI, respectively). Current smoking was associated with the obstructive phenotype in participants older than 10 years (aOR=1.24, 95% CI 1.05-1.46).

    CONCLUSION: Obstructive and restrictive phenotypes were found to be relatively prevalent during childhood, which supports the early origins concept. Several well-known respiratory risk factors were associated with the obstructive phenotype, whereas only low BMI was associated with the restrictive phenotype, suggesting different underlying pathobiology of these two phenotypes.


    Copyright ©The authors 2021.

    Publikations ID: 34881328
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt